Annual Operating Expenses
$40.89 M
+$3.94 M+10.68%
31 December 2023
Summary:
Armata Pharmaceuticals annual total operating expenses is currently $40.89 million, with the most recent change of +$3.94 million (+10.68%) on 31 December 2023. During the last 3 years, it has risen by +$19.30 million (+89.42%). ARMP annual operating expenses is now -28.52% below its all-time high of $57.21 million, reached on 31 December 2000.ARMP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$9.76 M
-$2.16 M-18.11%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly total operating expenses is currently $9.76 million, with the most recent change of -$2.16 million (-18.11%) on 30 September 2024. Over the past year, it has dropped by -$580.00 thousand (-5.61%). ARMP quarterly operating expenses is now -75.50% below its all-time high of $39.81 million, reached on 31 December 2000.ARMP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | -5.6% |
| 3 y3 years | +89.4% | +58.8% |
| 5 y5 years | +286.0% | +44.0% |
ARMP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +89.4% | -18.1% | +61.3% |
| 5 y | 5 years | at high | +286.0% | -18.1% | +162.8% |
| alltime | all time | -28.5% | +772.2% | -75.5% | +253.7% |
Armata Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.76 M(-18.1%) |
| June 2024 | - | $11.91 M(+16.5%) |
| Mar 2024 | - | $10.23 M(+6.8%) |
| Dec 2023 | $40.89 M(+10.7%) | $9.58 M(-7.3%) |
| Sept 2023 | - | $10.34 M(+7.3%) |
| June 2023 | - | $9.63 M(-15.1%) |
| Mar 2023 | - | $11.35 M(+9.9%) |
| Dec 2022 | $36.95 M(+55.1%) | $10.33 M(+19.8%) |
| Sept 2022 | - | $8.62 M(-6.5%) |
| June 2022 | - | $9.22 M(+5.1%) |
| Mar 2022 | - | $8.78 M(+45.1%) |
| Dec 2021 | $23.82 M(+10.4%) | $6.05 M(-1.5%) |
| Sept 2021 | - | $6.14 M(-0.9%) |
| June 2021 | - | $6.20 M(+14.0%) |
| Mar 2021 | - | $5.43 M(-15.8%) |
| Dec 2020 | $21.59 M(+13.1%) | $6.45 M(+14.8%) |
| Sept 2020 | - | $5.62 M(+22.5%) |
| June 2020 | - | $4.59 M(-6.7%) |
| Mar 2020 | - | $4.92 M(+32.5%) |
| Dec 2019 | $19.09 M(+80.2%) | $3.71 M(-45.2%) |
| Sept 2019 | - | $6.78 M(+31.4%) |
| June 2019 | - | $5.16 M(+49.9%) |
| Mar 2019 | - | $3.44 M(-180.6%) |
| Dec 2018 | $10.59 M(+1.2%) | -$4.27 M(-275.8%) |
| Sept 2018 | - | $2.43 M(-20.4%) |
| June 2018 | - | $3.05 M(-0.1%) |
| Mar 2018 | - | $3.06 M(+28.1%) |
| Dec 2017 | $10.47 M(-25.7%) | $2.38 M(+204.2%) |
| Sept 2017 | - | $784.00 K(-80.0%) |
| June 2017 | - | $3.91 M(+15.5%) |
| Mar 2017 | - | $3.39 M(+44.8%) |
| Dec 2016 | $14.09 M(+31.7%) | $2.34 M(-31.9%) |
| Sept 2016 | - | $3.44 M(-6.9%) |
| June 2016 | - | $3.69 M(-20.2%) |
| Mar 2016 | - | $4.62 M(+50.7%) |
| Dec 2015 | $10.70 M(-15.4%) | $3.07 M(+19.3%) |
| Sept 2015 | - | $2.57 M(-4.6%) |
| June 2015 | - | $2.69 M(+13.7%) |
| Mar 2015 | - | $2.37 M(-11.4%) |
| Dec 2014 | $12.65 M(+1.5%) | $2.67 M(-23.5%) |
| Sept 2014 | - | $3.49 M(-9.2%) |
| June 2014 | - | $3.85 M(+45.9%) |
| Mar 2014 | - | $2.64 M(+13.0%) |
| Dec 2013 | $12.46 M(+165.9%) | $2.33 M(-0.2%) |
| Sept 2013 | - | $2.34 M(-63.7%) |
| June 2013 | - | $6.44 M(+375.1%) |
| Mar 2013 | - | $1.35 M(-52.7%) |
| Dec 2012 | $4.69 M(-77.7%) | - |
| Sept 2009 | - | $2.87 M(-2.0%) |
| June 2009 | - | $2.93 M(-15.9%) |
| Mar 2009 | - | $3.48 M(-27.0%) |
| Dec 2008 | $21.00 M(-15.1%) | $4.77 M(+6.1%) |
| Sept 2008 | - | $4.49 M(-24.0%) |
| June 2008 | - | $5.91 M(+1.3%) |
| Mar 2008 | - | $5.83 M(-17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $24.74 M(-44.5%) | $7.08 M(+27.1%) |
| Sept 2007 | - | $5.57 M(-18.7%) |
| June 2007 | - | $6.84 M(-80.6%) |
| Mar 2007 | - | $35.25 M(+524.4%) |
| Dec 2006 | $44.59 M(+81.9%) | $5.64 M(+17.4%) |
| Sept 2006 | - | $4.81 M(-83.4%) |
| June 2006 | - | $28.97 M(+461.7%) |
| Mar 2006 | - | $5.16 M(-5.8%) |
| Dec 2005 | $24.51 M(+2.4%) | $5.48 M(-10.8%) |
| Sept 2005 | - | $6.14 M(-5.0%) |
| June 2005 | - | $6.47 M(+0.7%) |
| Mar 2005 | - | $6.42 M(+20.9%) |
| Dec 2004 | $23.94 M(+5.5%) | $5.31 M(-7.5%) |
| Sept 2004 | - | $5.74 M(-16.7%) |
| June 2004 | - | $6.89 M(+15.1%) |
| Mar 2004 | - | $5.99 M(+0.4%) |
| Dec 2003 | $22.69 M(-40.0%) | $5.96 M(+17.4%) |
| Sept 2003 | - | $5.08 M(-11.9%) |
| June 2003 | - | $5.76 M(-1.9%) |
| Mar 2003 | - | $5.88 M(-2.5%) |
| Dec 2002 | $37.82 M(-20.4%) | $6.03 M(-35.4%) |
| Sept 2002 | - | $9.33 M(-14.1%) |
| June 2002 | - | $10.86 M(-6.3%) |
| Mar 2002 | - | $11.60 M(-27.8%) |
| Dec 2001 | $47.48 M(-17.0%) | $16.07 M(-353.1%) |
| Sept 2001 | - | -$6.35 M(-166.1%) |
| June 2001 | - | $9.60 M(-3.4%) |
| Mar 2001 | - | $9.94 M(-75.0%) |
| Dec 2000 | $57.21 M(+193.4%) | $39.81 M(+541.1%) |
| Sept 2000 | - | $6.21 M(+3.4%) |
| June 2000 | - | $6.01 M(+16.0%) |
| Mar 2000 | - | $5.18 M(-9.2%) |
| Dec 1999 | $19.50 M(+8.9%) | $5.70 M(+14.0%) |
| Sept 1999 | - | $5.00 M(+11.1%) |
| June 1999 | - | $4.50 M(+2.3%) |
| Mar 1999 | - | $4.40 M(-25.4%) |
| Dec 1998 | $17.90 M(+2.9%) | $5.90 M(+51.3%) |
| Sept 1998 | - | $3.90 M(+2.6%) |
| June 1998 | - | $3.80 M(-13.6%) |
| Mar 1998 | - | $4.40 M(-24.1%) |
| Dec 1997 | $17.40 M(+6.7%) | $5.80 M(+52.6%) |
| Sept 1997 | - | $3.80 M(-2.6%) |
| June 1997 | - | $3.90 M(0.0%) |
| Mar 1997 | - | $3.90 M(-33.9%) |
| Dec 1996 | $16.30 M(+37.0%) | $5.90 M(+34.1%) |
| Sept 1996 | - | $4.40 M(+46.7%) |
| June 1996 | - | $3.00 M(0.0%) |
| Mar 1996 | - | $3.00 M(-30.2%) |
| Dec 1995 | $11.90 M(+19.0%) | $4.30 M(+87.0%) |
| Sept 1995 | - | $2.30 M(-8.0%) |
| June 1995 | - | $2.50 M(-7.4%) |
| Mar 1995 | - | $2.70 M(-25.0%) |
| Dec 1994 | $10.00 M(+69.5%) | $3.60 M(+50.0%) |
| Sept 1994 | - | $2.40 M(+9.1%) |
| June 1994 | - | $2.20 M |
| Dec 1993 | $5.90 M | - |
FAQ
- What is Armata Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual operating expenses year-on-year change?
- What is Armata Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly operating expenses year-on-year change?
What is Armata Pharmaceuticals annual total operating expenses?
The current annual operating expenses of ARMP is $40.89 M
What is the all time high annual operating expenses for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual total operating expenses is $57.21 M
What is Armata Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, ARMP annual total operating expenses has changed by +$3.94 M (+10.68%)
What is Armata Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of ARMP is $9.76 M
What is the all time high quarterly operating expenses for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly total operating expenses is $39.81 M
What is Armata Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, ARMP quarterly total operating expenses has changed by -$580.00 K (-5.61%)